Oliver Schnell

Director/Board Member at B. Braun SE

Health Technology

Profile

Oliver Schnell is currently a Member-Supervisory Board at B.
Braun SE.
He previously served as a Member-Supervisory Board at B.
Braun Melsungen AG.

Oliver Schnell active positions

Companies	Position	Start
B. Braun SE B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.	Director/Board Member	-

All active positions of Oliver Schnell

Former positions of Oliver Schnell

Companies	Position	End
B. Braun Melsungen AG B. Braun Melsungen AG Pharmaceuticals: MajorHealth Technology B. Braun Melsungen AG manufactures and distributes pharmaceutical products and medical equipment. Its products are used in the treatment of degenerative spinal diseases, diabetes management, nutritional therapy, extracorporeal blood treatment, laparoscopy, neurosurgery, wound management, and urology. The company was founded on June 23, 1839 and is headquartered in Melsungen, Germany.	Director/Board Member	-

See the detail of Oliver Schnell's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Oliver Schnell's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
B. Braun Melsungen AG B. Braun Melsungen AG Pharmaceuticals: MajorHealth Technology B. Braun Melsungen AG manufactures and distributes pharmaceutical products and medical equipment. Its products are used in the treatment of degenerative spinal diseases, diabetes management, nutritional therapy, extracorporeal blood treatment, laparoscopy, neurosurgery, wound management, and urology. The company was founded on June 23, 1839 and is headquartered in Melsungen, Germany.	Health Technology
B. Braun SE B. Braun SE Pharmaceuticals: MajorHealth Technology Part of B. Braun Holding GmbH & Co. KG, B. Braun SE is a global healthcare company based in Melsungen, Germany. The German company offers a wide range of medical equipment and healthcare solutions, including efficient and life-saving extracorporeal blood treatments such as hemodialysis, acute dialysis, and apheresis. B. Braun has more than 360 dialysis and care centers worldwide, providing the best possible care for patients with chronic diseases. The company was founded in 2018, and Anna Maria Braun has been the CEO of the company since 2019.	Health Technology